BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) today announced that President and CEO Jeffrey S. Thiede and Vice President and Chief Financial Officer Maximillian J Marcy will ...

BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd (Anteris or the Company) (ASX: AVR), a structural heart company developing the world’s only balloon-expandable, ...

ENGLEWOOD, Colo., Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

Okay. Great. Good afternoon, everyone, and welcome to the next session at the Cantor Global Healthcare Conference. Really glad -- I'm Steve Seedhouse on the Cantor biotech team. Really glad to be ...

CAMBRIDGE, Mass., Aug. 28, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase ...

ROCK HILL, S.C., March 04, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today that the Company will participate in the Cantor Global Technology Conference on March 11, 2025. President and ...

Rezolve Ai's CEO, Daniel M. Wagner, will present at the Cantor Global Technology Conference on March 11-12, 2025. Rezolve Ai, a leading provider of AI-driven retail solutions, announced that its ...

THORNTON, Colo., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, ...

ROCHESTER, N.Y., June 15, 2023 /PRNewswire/ -- Hyzon Motors Inc. (NASDAQ: HYZN) ("Hyzon" or the "Company"), a high-power hydrogen fuel cell technology developer and global supplier of zero-emission ...

Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat ...